- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/39 - Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
Patent holdings for IPC class A61K 39/39
Total number of patents in this class: 6032
10-year publication summary
|
377
|
497
|
437
|
544
|
533
|
624
|
554
|
606
|
565
|
155
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1701 |
177 |
| Immatics Biotechnologies GmbH | 1144 |
98 |
| Novartis AG | 11238 |
66 |
| The Regents of the University of California | 18943 |
61 |
| The Trustees of the University of Pennsylvania | 4122 |
53 |
| President and Fellows of Harvard College | 5792 |
51 |
| Modernatx, Inc. | 1181 |
51 |
| Duke University | 2872 |
49 |
| Massachusetts Institute of Technology | 9795 |
45 |
| Zoetis Services LLC | 1537 |
41 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
36 |
| Access to Advanced Health Institute | 75 |
35 |
| Children's Medical Center Corporation | 1780 |
34 |
| Toray Industries, Inc. | 6652 |
33 |
| Merck Sharp & Dohme LLC | 3689 |
32 |
| Board of Regents, The University of Texas System | 5370 |
31 |
| Osaka University | 3143 |
29 |
| The Johns Hopkins University | 5377 |
28 |
| Riken | 1669 |
27 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
26 |
| Other owners | 5029 |